K
KalVista Pharmaceuticals D
D
KALV
12.010
USD
-0.15
(-1.23%)
مفتوح الان
حجم التداول
18,267
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
597,084,788
العنوان: KalVista Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.